Clinical Trials Logo

Endometrioid Endometrial Cancer clinical trials

View clinical trials related to Endometrioid Endometrial Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT05997017 Recruiting - Cancer Clinical Trials

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

Start date: December 28, 2023
Phase: Phase 2
Study type: Interventional

A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer

NCT ID: NCT05705505 Recruiting - Clinical trials for Endometrioid Endometrial Cancer

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

Start date: March 29, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This study will assess the safety and efficacy of increasing doses of narazaciclib (ON 123300) in combination with the standard daily dose (2.5mg) of letrozole in patients with Recurrent Metastatic Low-grade Endometrioid Endometrial Cancer and other Gynecologic Malignancies.

NCT ID: NCT03909152 Active, not recruiting - Clinical trials for Endometrioid Endometrial Cancer

A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone

Start date: May 2, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test any good and bad effect of the study drug, onapristone extended-release (ER) alone and in combination with anastrozole.